This is a demo store. No orders will be fulfilled.
自噬
选项
-
PHA-848125,ATP竞争性CDK2和TRKA抑制剂CAS号: 802539-81-7分子式: C25H32N8O 分子量: 460.57IUPAC Name: N,1,4,4-tetramethyl-8-[4-(4-methylpiperazin-1-yl)anilino]-5H-pyrazolo[4,3-h]quinazoline-3-carboxamideSMILES: CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)CInChIKey: RXZMYLDMFYNEIM-UHFFFAOYSA-NInChI: 1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)
-
SU 9516,cyclin依赖性激酶(cdk)抑制剂CAS号: 377090-84-1 Compound CID : 5289419分子式: C13H11N3O2 分子量: 241.25IUPAC Name: (3Z)-3-(1H-imidazol-5-ylmethylidene)-5-methoxy-1H-indol-2-oneSMILES: COC1=CC2=C(C=C1)NC(=O)C2=CC3=CN=CN3InChIKey: QNUKRWAIZMBVCU-WCIBSUBMSA-NInChI: 1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-
-
Purvalanol A,CDK抑制剂CAS号: 212844-53-6 Compound CID : 456214分子式: C19H25ClN6O 分子量: 388.9IUPAC Name: (2R)-2-[[6-(3-chloroanilino)-9-propan-2-ylpurin-2-yl]amino]-3-methylbutan-1-olSMILES: CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC=C3)ClInChIKey: PMXCMJLOPOFPBT-HNNXBMFYSA-NInChI: 1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1
-
SU9516CAS号: 666837-93-0 Compound CID : 24906268分子式: C13H11N3O2 分子量: 241.25IUPAC Name: 3-(1H-imidazol-5-ylmethylidene)-5-methoxy-1H-indol-2-oneSMILES: COC1=CC2=C(C=C1)NC(=O)C2=CC3=CN=CN3InChIKey: QNUKRWAIZMBVCU-UHFFFAOYSA-NInChI: 1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)
-
SU 9516CAS号: 377090-84-1 Compound CID : 5289419分子式: C13H11N3O2 分子量: 241.25IUPAC Name: (3Z)-3-(1H-imidazol-5-ylmethylidene)-5-methoxy-1H-indol-2-oneSMILES: COC1=CC2=C(C=C1)NC(=O)C2=CC3=CN=CN3InChIKey: QNUKRWAIZMBVCU-WCIBSUBMSA-NInChI: 1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-
首页
400-620-6333




